Phenotypic expression of gastrointestinal differentiation markers in colorectal adenocarcinomas with liver metastasis

Pathology

Volumn 34, Issue 6, 2002, Pages 556-560

  Yao, Takashi ^a   Takata, Miyuki ^a   Tustsumi, Shuichi ^a   Nishiyama, Ken Ichi ^a   Taguchi, Ken Ichi ^a   Nagai, Eishi ^a   Tsuneyoshi, Masazumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

CD10; Colorectal carcinoma; Human gastric mucin; Liver metastasis; MUC2

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; MUCIN 2; STOMACH MUCIN;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER INVASION; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LAPAROTOMY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PROTEIN EXPRESSION; RISK ASSESSMENT;

EID: 0036915033     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/0031302021000035965-4     Document Type: Article

References (38)

1. Almersjö O, Bengmark S, Hafstrom L. Liver metastases found by follow-up of patients operated on for colorectal cancer. Cancer 1976; 37: 1454-7.
2. Foster JH. Survival after resection for secondary tumors. Am J Surg 1978; 135: 389-94.
3. Baba H, Watanabe O, Itano O, et al. Clinicopathological analysis of liver metastasis from colorectal cancer. J Jpn Soc Coloproctol 1999; 52: 169-78.
4. Shiiki S, Fuchimoto S, Iwagaki H, et al. Clinicopathological study on colorectal cancer with synchronous liver metastasis. J Jpn Soc Coloproctol 1991; 44: 1107-12.
5. Adachi Y, Inomata M, Kakisako K, Sato K, Shiraishi N, Kitano S. Histopathologic characteristics of colorectal cancer with liver metastasis. Dis Colon Rectum 1999; 42: 1053-6.
6. Onodera H, Arii S, Imamura M. Prediction of liver metastasis of colorectal cancer with regard to molecular biological studies. J Jpn Soc Coloproctol 1998; 51: 1118-24.
7. Kortz WJ, Meyers WC, Hanks JB, Schirmer BD, Jones RS. Hepatic resection for metastatic cancer. Ann Surgery 1984; 199: 182-6.
8. Coppa GF, Eng K, Ranson JH, Gouge TH, Localio SA. Hepatic resection for metastatic colon and rectal cancer. An evaluation of preoperative and postoperative factors. Ann Surgery 1985; 202: 203-8.
9. Talbot IC, Ritchie S, Leighton MH, Hughes AO, Bussey HJ, Morson BC. The clinical significance of invasion of veins by rectal cancer. Br J Surg 1980; 67: 439-42.
10. Krasna MJ, Flancbaum L, Cody RP, Shneibaum S, Ben Ari G. Vascular and neural invasion in colorectal carcinoma. Incidence and prognostic significance. Cancer 1988; 61: 1018-23.
11. Ono M, Sakamoto M, Ino Y, et al. Cancer cell morphology at the invasion front and expression of cell adhesion-related carbohydrate in the primary lesion of patients with colorectal carcinoma with liver metastasis. Cancer 1996; 78: 1179-86.
12. Oshima H, Sawada T, Saitou Y, et al. Early colonic cancer associated with liver and bone metastasis, report of a case. (Japanese.) Stomach Intestine 1994; 29: 1293-6.
13. Nakamura Y, Sagara M, Maenohara S, et al. Submucosal invasive carcinoma of the sigmoid colon, recurring as liver metastasis one year and five months postoperatively, report of a case. (Japanese.) Stomach Intestine 1994; 29: 1297-301.
14. Dirschmid K, Lang A, Mathis G, Haid A, Hansen M. Incidence of extramural venous invasion in colorectal carcinoma. Finding with a new technique. Hum Pathol 1996; 27: 1227-30.
15. Shimoda T, Fujisaki J, Kashimura H, et al. Histological type of gastric carcinoma in relationship to the mode of intramucosal spreading of cancer cells. (Japanese.) Stomach Intestine 1991; 26: 1125-34.
16. Tatematsu M, Ichinose M, Miki K, Hasegawa R, Kato T, Ito N. Gastric and intestinal phenotypic expression of human stomach cancers as revealed by pepsinogen immunohistochemistry and mucin histochemistry. Acta Pathol Jpn 1990; 40: 494-504.
17. Yao T, Kabashima A, Kouzuki T, Oya M, Tsuneyoshi M. The phenotypes of the gastric carcinoma-evaluation by a new immunohistochemical methods. (Japanese.) Stomach Intestine 1999; 34; 477-85.
18. Kabashima A, Yao T, Sugimachi K, Tsuneyoshi M. Gastric or intestinal phenotypic expression in the carcinomas and background mucosa of multiple early gastric carcinomas. Histopathology 2000; 37; 513-22.
19. Egashira Y. Mucin histochemical study of differentiated adenocarcinoma of stomach. (Japanese.) Jpn J Gastroenterol 1994; 91; 839-48.
20. Koseki K, Takizawa T, Koike M, Funata N, Hishima T. Subclassification of well differentiated gastric cancer with reference to biological behavior and malignancy, gastric type vs. intestinal type, and papillary carcinoma vs. tubular carcinoma. (Japanese.) Stomach Intestine 1999; 34: 507-11.
21. Yao T, Tsutsumi S, Akaiwa Y, et al. Phenotypic expression of colorectal adenocarcinoma with reference to tumor development and biological behavior. Jpn J Cancer Res 2001; 92: 755-61.
22. Japanese Society for Cancer of the Colon and Rectum. Japanese Classification of Colorectal Carcinoma. 1st English Ed. Tokyo: Kanehara & Co, 1997.
23. Ho SB, Niehans GA, Lyftogt C, et al. Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res 1993; 53: 641-51.
24. Chang SK, Dohrman AF, Basbaum CB, et al. Localization of mucin (MUC2 and MUC3) messenger RNA and peptide expression in human normal intestine and colon cancer. Gastroenterology 1994; 107: 28-36.
25. Weiss AA, Babyatsky MW, Ogata S, Chen A, Itzkowitz SH. Expression of MUC2 and MUC3 mRNA in human normal, malignant, and inflammatory intestinal tissues. J Histochem Cytochem 1996; 44: 1161-6.
26. Danielsen EM, Vyas JP, Kenny AJ. A neutral endopeptidase in the microvillar membrane of pig intestine. Partial purification and properties. Biochem J 1980; 191: 645-8.
27. Metzgar RS, Borowitz MJ, Jones NH, Dowell BL. Distribution of common acute lymphoblastic leukemia antigen in nonhematopoietic tissue. J Exp Med 1981; 154: 1249-54.
28. Trejdosiewicz LK, Malizia G, Oakes J, Losowsky MS, Janossy G. Expression of the common acute lymphoblastic leukemia antigen (CALLA gp 100) in the brush border of normal jejunum and jejunum of patients with coeliac disease. J Clin Pathol 1985; 38: 1002-6.
29. Endoh Y, Tamura G, Motoyama T, Ajioka Y, Watanabe H. Well-differentiated adenocarcinoma mimicking complete-type intestinal metaplasia in the stomach. Hum Pathol 1999; 30: 826-32.
30. Bara J, Loisillier F, Burtin P. Antigens of gastric and intestinal mucous cells in human colonic tumours. Br J Cancer 1980; 41: 209-21.
31. Bara J, Gautier R, Mouradian P, Decaens C, Daher N. Oncofetal mucin M1 epitope family: Characterization and expression during colonic carcinogenesis. Int J Cancer 1991; 47: 304-10.
32. Nagai E, Yao T, Sakamoto M, Akazawa K, Utsunomiya T, Tsuneyoshi M. Risk factors related liver metastasis in colorectal carcinoma: A multivariate analysis of clinicopathologic and immunohistochemical variables. Jpn J Cancer Res 1994; 85: 1280-7.
33. Hanski C, Riede E, Gratchev A, Foss HD, Bohm C, Klussmann E. MUC2 gene suppression in human colorectal carcinomas and their metastases: In vitro evidence of the modulatory role of DNA methylation. Lab Invest 1997; 77: 685-95.
34. Shimizu S, Yamada N, Sawada T, et al. Ultrastructure of early phase of hepatic metastasis of human colonic carcinoma cells with special reference to desmosomal junctions with hepatocytes. Pathol Int 2000; 50: 953-9.
35. Adachi Y, Yamamoto H. Itoh F, Okada Y, Imai K. Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers. Gut 1999: 45: 252-8.
36. Hida J, Matsuda T, Kitaoka M, Machidera N, Kubo R, Yasutomi M. The role of basement membrane in colorectal cancer invasion and liver metastasis. Cancer 1994; 74: 592-8.
37. Ishigami S-I, Arii S, Niwano M, et al. Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer. Br J Cancer 1998; 78; 1379-84.
38. Oyama K, Nishimura G, Ohta T, Shinozawa K, Ninomiya I, Fushida S. Fas-ligand expression in human colorectal cancers. J Jpn Soc Coloproctol 2001; 54: 545-50.